We establish the crucial link between corporates and investors by providing tailor made information and facilitating a direct dialogue
Our capital market products are especially designed to suit the needs of investors and companies active in the mid and small cap segment
All our team members have been active in their respective sectors for more than 20 years, ensuring the highest quality of our research efforts
We provide individual capital market consulting services for corporats, investors and other parties such as banks or institutions
We produce a dedicated Equity Research product to investors in particular for mid and small caps, providing strong investment ideas, continuous updates and direct company access.
We take care of all Capital Market needs, combining high quality equity research with numerous services such as the identification and update of suitable investors as well as roadshow management.
We enable investment banks to Outsource parts of their equity research in order to rightsize their product while making use of our outstanding experience in specific sectors.
A selection of key features that form the broad service offering to our various clients
All information in one place
Direct investor communication
Unrivaled sector expertise
Producing strong investment ideas
Enhancing the share's liquidity
Extensive IPO and M&A experience
Value generation in figures
Identifying the right investors
Going beyond equity
Our Analysts combine their in-depth knowlege of the capital markets with a long-standing exposure to specific industry sectors, This has made them interesting sparring partners for investors, corporates and other industry experts.
Please do not hesitate to contact any of the key representatives of Matelan Research
Each of Matelan's research analysts is in equity research for more than 20 years. In their carrier, Matelan's analysts have received numerous rankings and built-up close relations with a wide variety of investors. In addition, they all have participated in a number of IPO and M&A projects.
Fair Value: €92.4 - - - - Rating: Strong Buy
Fair Value: 22.6€ - - - - - - - Rating: Buy
Fair Value: 110.3€ - - - - - Rating: Neutral